50.41% | % of shares held by all insiders |
50.74% | % of shares held by institutions |
102.32% | % of float held by institutions |
121 | Number of institutions holding shares |
Holder | Shares | Date reported | % out | Value |
---|---|---|---|---|
QVT Financial LP | 129,393,817 | 30 Sept 2022 | 18.37% | 398,532,956 |
SB Investment Advisers (UK) LTD | 99,375,586 | 30 Sept 2022 | 14.11% | 306,076,804 |
Viking Global Investors, L.P. | 88,238,700 | 30 Sept 2022 | 12.53% | 271,775,196 |
Two Seas Capital LP | 5,869,690 | 30 Sept 2022 | 0.83% | 18,078,645 |
Blackrock Inc. | 5,315,979 | 30 Sept 2022 | 0.75% | 16,373,215 |
SC China Holding Ltd | 5,205,418 | 30 Sept 2022 | 0.74% | 16,032,687 |
Anchorage Capital Group, LLC | 4,832,642 | 30 Sept 2022 | 0.69% | 14,884,537 |
FMR, LLC | 4,175,030 | 30 Sept 2022 | 0.59% | 12,859,092 |
Adage Capital Partners GP L.L.C. | 3,700,000 | 30 Sept 2022 | 0.53% | 11,396,000 |
Woodline Partners LP | 2,499,335 | 30 Sept 2022 | 0.35% | 7,697,951 |
Holder | Shares | Date reported | % out | Value |
---|---|---|---|---|
Fidelity Growth Company Fund | 7,031,255 | 30 Nov 2022 | 1.00% | 33,046,898 |
Fidelity Select Portfolios - Biotechnology | 5,957,525 | 30 Nov 2022 | 0.85% | 28,000,367 |
iShares NASDAQ Biotechnology ETF | 2,935,301 | 31 Dec 2022 | 0.42% | 20,693,872 |
SPDR (R) Ser Tr-SPDR (R) S&P (R) Biotech ETF | 2,453,696 | 31 Dec 2022 | 0.35% | 17,298,556 |
Fidelity Growth Company K6 Fund | 2,094,738 | 30 Nov 2022 | 0.30% | 9,845,268 |
Fidelity Series Growth Company Fund | 2,030,300 | 30 Nov 2022 | 0.29% | 9,542,410 |
Vanguard Extended Market Index Fund | 1,362,029 | 30 Sept 2022 | 0.19% | 4,195,049 |
Mutual Fund Ser Tr-Eventide Healthcare & Life Sciences Fund | 990,300 | 30 Sept 2022 | 0.14% | 3,050,124 |
Fidelity Extended Market Index Fund | 520,440 | 30 Nov 2022 | 0.07% | 2,446,068 |
Schwab Strategic Tr-Schwab U.S. Small Cap ETF | 444,779 | 30 Nov 2022 | 0.06% | 2,090,461 |